Dear Editor, We have read with great interest the paper by Van Laar ES and colleagues entitled BProfessional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers.^[1]. We strongly agree that surveys are paramount to detect health care providers needs and plan interventions. However, we would like to highlight a criticism on the results of the survey on the specific concern of CINV management in patients undergoing bone marrow transplant (BMT). This topic is not specifically discussed in the paper. In table 4, when survey results among hematologists/oncologists are reported topic by topic, the second lowest percentage of Bstrong agreementâ nd the highest percentage of Bdisagreement^in the judgment of physicians, with nurse judgment just barely better, are reported for the issue BPrevent/manage CINV in patients undergoing bone marrow transplant.Î t is our opinion that interviewers were not particularly expert in the field of BMT with a low educational need on CINV management in this setting. Indeed, CINV management in BMT is complex [2], knowledge of health care providers is limited, adherence to guidelines is low [3] , and moreover, the strength of guidelines recommendations for CINV management in high-dose chemotherapy is weak, when compared with recommendations for CINV in standard-dose chemotherapy [4]; consequently, contrary to what the reader might deduce, we strongly believe that health care providers need in the field of BMT is high, so that, in order to verify our opinion, we suggest to disseminate the same survey to physicians and nurses operating in this field.
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